Get started
Author

Bram Bongers

Evidence‐based standardized sample handling protocol for accurate blood‐based Alzheimer's disease biomarker measurement: Results and consensus of the Global Biomarker Standardization Consortium
2025 · Inge M. W. Verberk, Mariam Gouda, et al. · Alzheimer s & Dementia · 34
Utilization of fluid-based biomarkers as endpoints in disease-modifying clinical trials for Alzheimer’s disease: a systematic review
2024 · Marlies Oosthoek, Lisa Vermunt, et al. · Alzheimer s Research & Therapy · 28
PDF
The use of synaptic biomarkers in cerebrospinal fluid to differentiate behavioral variant of frontotemporal dementia from primary psychiatric disorders and Alzheimer’s disease
2024 · Shreyasee Das, Marie-Paule E. van Engelen, et al. · Alzheimer s Research & Therapy · 12
PDF
Plasma and MRI biomarkers capture neuronal damage in former professional boxers
2025 · Suzie Kamps, Suzan van Amerongen, et al. · Scientific Reports · 3
PDF
Plasma phosphorylated tau 217 levels are highly stable under common pre‐analytical sample handling procedures
2023 · Mariam Gouda, Daniel Antwi‐Berko, et al. · Alzheimer s & Dementia · 3
PDF
Development and validation of a novel panel of CSF biomarkers for Alzheimer’s disease
2026 · Yanaika S. Hok-A-Hin, Bram Bongers, et al. · Alzheimer s Research & Therapy · 2
Cerebrospinal fluid biomarkers and cognitive trajectories in patients with Alzheimer’s disease and a history of traumatic brain injury
2024 · Suzan van Amerongen, Shreyasee Das, et al. · Neurobiology of Aging · 1
APOE ε4 carriership status enhances age-related changes in Alzheimer’s disease plasma biomarkers concentrations
2026 · Rebecca Z. Rousset, Anouk den Braber, et al. · Nature Communications
PDF
APOE ε4 carriership status enhances age-related changes in Alzheimer’s disease plasma biomarkers concentrations
2026 · Rebecca Rousset, Anouk den Braber, et al. · Research Square
PDF
Plasma SNAP25 is increased in pre-clinical Alzheimer's disease and has prognostic value for cognitive decline and disease progression: a multi-cohort study
2025 · Shreyasee Das, Calvin Trieu, et al. · Research Square
PDF
Utilization and future of biomarkers in biofluid as outcome measures in clinical trials for Alzheimer’s disease: a systematic review
2023 · Marlies Oosthoek, Lisa Vermunt, et al. · Alzheimer s & Dementia
PDF
Differential Expression of Synaptic Biomarkers in the Cerebrospinal Fluid Differentiates Behavioural Variant of Frontotemporal Dementia from Primary Psychiatric Disorders and Alzheimer’s Disease
2023 · Shreyasee Das, Marie‐Paule E. van Engelen, et al. · Alzheimer s & Dementia
PDF
Works count: 20
Citation count: 83
H-index: 3
I10-index: 3
Year
Topic
Type